Newdrug P.C. is a start-up Biotechnology Company established in January 2017, with expertise in Drug Discovery and Development. It is located at Patras Science Park nearby the University of Patras.

The Research and Development group of Newdrug mainly focuses in finding solutions for the treatment of, multiple sclerosis, hypertension and cancer. In particular, Newdrug specializes in bioactive peptides and mimetics for important peptides such as Angiotensin (AngII), Gonadotropin Realising Hormone (GnRH), Myelin epitopes and Thrombin Receptor activating peptides (TRAP). Newdrug also specializes in synthesis, full characterization and purity determination of peptide mimetics.